Harmony Biosciences Holdings, Inc. HRMY

Business rating

Price rating

$35.99Price on 6 Sept

$56.41 +56.7%Fair value estimate

Cash flow statement

currency values in millions of USD

Strong OCF/FCF, high liquidity, low net leverage, and excellent coverage ratios outweigh minor concerns; cash flows indicate financial strength.

Fiscal Year	2024	2023	2022	2021	2020	2019	2018
Period Ending	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Net Income	145.5	128.9	181.5	34.6	-36.9	-152	-39.9
Depreciation & Amortization	24.1	24.4	23.4	18.8	10.2	3.2	0.2
Stock-Based Compensation	42.6	31.7	26.2	15.7	4.7	9.9	1.1
Change in Working Capital	0	35	-4.1	0.6	-11.6	8.3	-0.2
Accounts Receivables	-8.9	-19.4	-19.9	-12.7	-17.9	-4.3	0
Inventory	-1.8	-1.1	0.1	-0.6	-2.7	-1.1	0
Accounts Payables	0	8.9	2.8	-1.6	-3.8	4.9	-0.6
Other Working Capital	0	46.6	12.9	15.5	12.8	8.7	0.4
Other Non-Cash Items	36.9	12.9	3.5	2.7	4.9	55.1	2.1
Operating Cash Flow	219.8	219.4	144.5	98.6	-3	-75.4	-38.8
Investments in PP&E	-1.2	-0.3	-40.2	-100.3	-2	-127.1	-1.3
Capital Expenditure	-1.2	-0.3	-40.2	-100.3	-2	-127.1	-1.3
Acquisitions	-33.1	-37	141.8	-100	-2	-52	0
Purchases of Investments	-105.3	-127.5	-110.7	0	0	0	0
Sales/Maturities of Investments	98.5	118.3	9.1	0	0	0	0
Other Investing Activities	-26.5	0	-141.8	100	2	52	0
Investing Cash Flow	-67.5	-46.4	-141.8	-100.3	-2	-127.1	-1.3
Net Debt Issuance	-15	-1.3	-2	-0.5	79.4	100	0
Long-Term Net Debt Issuance	-15	-1.3	-2	-0.5	79.4	100	0
Short-Term Net Debt Issuance	0	0	0	0	0	0	0
Net Stock Issuance	0	-100.5	0	30	-0.2	0	21.8
Net Common Stock Issuance	0	-100	0	30	147.5	0	-3.2
Common Stock Issuance	0	0	8.8	30	147.6	50.1	0
Common Stock Repurchased	0	-100	0	0	-0.2	-1.1	-3.2
Net Preferred Stock Issuance	0	-0.5	0	0	-147.6	50	25
Net Dividends Paid	0	0	0	0	0	0	0
Common Dividends Paid	0	0	0	0	0	0	0
Preferred Dividends Paid	0	0	0	0	0	0	0
Other Financing Activities	4	-3.8	8.8	-22.1	129.9	43.8	-0.2
Financing Cash Flow	-11	-105.6	6.8	7.4	209.2	143.8	21.6
Effect of Forex Changes on Cash	0	0	0	0	0	0	0
Cash at Beginning of Period	311.9	244.5	235.1	229.4	25.2	84	102.5
Cash at End of Period	453.3	311.9	244.5	235.1	229.4	25.2	84
Net Cash Flow	141.3	67.4	9.5	5.7	204.2	-58.8	-18.5
Free Cash Flow	218.7	219.1	104.3	-1.7	-5	-202.6	-40.1
Cash Interest Paid	0	20.1	16.4	19.8	0	0	0
Cash Income Taxes Paid	79.6	48.2	12.6	2.9	0	0	0
All data is from our financial data partners, who compile data from SEC filings. Data errors are possible. If you spot one, please let us know.